atrial fibrillation
Conditions
Interventions
Research Group:APP Management
Sponsors
Xuzhou Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age>=18 years old, =2 points for men and >=3 points for women 4. The patient or a relative who has lived with him for a long time is using a smartphone
Exclusion criteria
Exclusion criteria: 1. Presence of moderate to severe valvular disease 2. Presence of congenital heart disease 3. Planned to receive atrial fibrillation catheter ablation or left atrial appendage occlusion treatment in the near future 4. Severe heart failure (cardiac function class VI, and/or EF <35%) and severe organic heart disease 5. Contraindications to anticoagulant therapy 6. Pregnant women 7. Have had or plan to undergo major surgical procedures in the near future 8. Estimated life expectancy < 12 months 9. Unable to communicate normally due to mental or intellectual disability, or hearing or language impairment 10. Unable to sign informed consent or refuse to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anticoagulant use rate at 12 months; | — |
Secondary
| Measure | Time frame |
|---|---|
| Other guideline recommended drug utilization rates;Number of emergency room visits and hospitalizations related to atrial fibrillation within 12 months;Number of nurse/doctor phone contacts; | — |
Countries
China
Contacts
Public ContactBing Han
Xuzhou Central Hospital
Outcome results
None listed